Articles On Probiotec (ASX:PBP)
Title | Source | Codes | Date |
---|---|---|---|
Megacap tech names lead US markets to new record
Megacap tech names led the broader market to another record close as Nvidia hit a new intraday all time high amid growing optimism about Fed rate cuts. The S&P 500 rose 0.77 per cent to finish at a new record 5,473.23. The tech heavy... |
ShareCafe | PBP | 6 months ago |
Megacap tech names lead US markets to new record
Megacap tech names led the broader market to another record close as Nvidia hit a new intraday all time high amid growing optimism about Fed rate cuts. The S&P 500 rose 0.77 per cent to finish at a new record 5,473.23. The tech heavy Na... |
ShareCafe | PBP | 6 months ago |
Soft US manufacturing data raises activity concerns
Cyclical stocks and those leveraged to manufacturing activity came under pressure during the trading session following the release of soft manufacturing numbers which raised concerns about the strength of the underlying US economy. The Do... |
ShareCafe | PBP | 6 months ago |
Soft US manufacturing data raises activity concerns
Cyclical stocks and those leveraged to manufacturing activity came under pressure during the trading session following the release of soft manufacturing numbers which raised concerns about the strength of the underlying US economy. The Dow... |
ShareCafe | PBP | 6 months ago |
ASX Health Winners in May: LTR Pharma leads, and why hopes are high for biotech stocks this year
S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month The S&P/ASX 200 Health Care [XHJ] closed flattish for the month o... |
Stockhead | PBP | 6 months ago |
Check Up: Alzheimer’s is ‘preventable’, so here’s what you must do; and recent ASX biotech winners
Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month The phrase ‘you are what you eat’ was coined almost a c... |
Stockhead | PBP | 7 months ago |
ASX Health Winners April: Mesoblast leads; and why the Health sector is just built different
ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month The S&P/ASX 200 Health Care [XHJ] had a soft month in April... |
Stockhead | PBP | 7 months ago |
Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners
There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month Scientists have made a significant b... |
Stockhead | PBP | 7 months ago |
MoneyTalks: Brokers name ASX-listed health stocks Percheron and Probiotec as ones to watch
Percheron could double if clinical goes well But Taylor Collison admits that PER is a speculative investment Probiotec meanwhile offers a resilient business model, says Sequoia Perceheron could double after trial readout at year-end Tay... |
Stockhead | PBP | 8 months ago |
MoneyTalks: Walk like an Egyptian, but Think like an Acquirer
MoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We’ll tap our extensive list of experts to hear what’s hot, their top picks, and what they’re looking out for. Today we hear from IML’s Marc W... |
Stockhead | PBP | 8 months ago |
Dow ends 3-day slump as PPI surpasses expectations
The Dow Jones Industrial Average fell Thursday and snapped a 3-day win streak after the release of hotter-than-expected U.S. inflation data sent Treasury yields higher, while Nvidia shares were under pressure. The 30-stock Dow pulled back... |
ShareCafe | PBP | 9 months ago |
Dow set to end 3-day slump as PPI surpasses expectations
Note: Figures recorded at 7:40am AEDT. Updated figures and a video recording will be available at 9am AEDT. The Dow Jones Industrial Average fell Thursday and snapped a 3-day win streak after the release of hotter-than-expected U.S. inflati... |
ShareCafe | PBP | 9 months ago |
Rudi’s View: CBA, GQG, Pilbara Minerals, Sonic Healthcare, Webjet & Xero
By Rudi Filapek-Vandyck, Editor FNArena M&A Is Back (With A Vengeance)Even the more casual observer would have noticed the high number of announcements regarding acquisitions and mergers this year, with troubled AI (?) company Appen ((A... |
FNArena | PBP | 9 months ago |
ASX Health Winners February: Law of attrition applies but biotech is a long term game; Nyrada up 5x last month
ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr... |
Stockhead | PBP | 9 months ago |
FNArena Corporate Results Monitor – 29-02-2024
Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((4DX)) - 4DMedical ((APM)) - APM Human Services International ((AMI)) - Aurelia Metals ((ACL)) - Australian Clinical Labs ((AVG)) - Australian Vintage ((AVD)) - Avada Gro... |
FNArena | PBP | 9 months ago |
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs
Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks There were a couple of big news from the world of biotec... |
Stockhead | PBP | 9 months ago |
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners
Xi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks China’s President Xi is expected... |
Stockhead | PBP | 1 year ago |
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff
News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks Goldman Sachs analysts said they will make no... |
Stockhead | PBP | 1 year ago |
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it
L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks Be... |
Stockhead | PBP | 1 year ago |
These are the ASX stocks Morgans thinks can push the health and wellness agenda
Morgans says companies on the ASX are propelling our appetite product for health and wellness products Bioxyne says Covid has shown our susceptibility to disease, but also how resilient and strong we are in fighting it Anagenics says it’s... |
Stockhead | PBP | 1 year ago |
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?
The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks On... |
Stockhead | PBP | 1 year ago |
Nasdaq drops as weekly jobless claims disappoint
The Nasdaq Composite fell for a fourth session Thursday as concerns resurfaced over the Federal Reserve’s interest rate policy path, as the latest jobless claims data has come in. The tech-heavy Nasdaq sold off 0.89 per cent to end at 13,... |
ShareCafe | PBP | 1 year ago |
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…
Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August August was all about earnings, and des... |
Stockhead | PBP | 1 year ago |
S&P 500 advances after release of fresh economic data
The S&P 500 advanced Wednesday for a four-day winning streak, as investors assess new US economic data. The broad-market index climbed 0.38 per cent, surpassing the 4,500 level, to close at 4,514.87. The Dow Jones Industrial Average a... |
ShareCafe | PBP | 1 year ago |
Check Up: Australian biotech sector continues to be a magnet for US investors
Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the best and worst performing ASX biotechs over the past month The Australian biotech sector co... |
Stockhead | PBP | 1 year ago |
FNArena Corporate Results Monitor – 28-08-2023
Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ALG)) - Ardent Leisure ((ABB)) - Aussie Broadband ((AFG)) - Australian Finance Group ((AVG)) - Australian Vintage ((BVS)) - Bravura Solutions ((CBO)) - Cobram Estate Oli... |
FNArena | PBP | 1 year ago |
Best calls to action – Monday, 28 August 2023
Today, Monday the 28th of August, we are happy to buy Wesfarmers (ASX:WES), Accent Group (ASX:AX1), Pilbara Minerals (ASX:PLS), Ventia Services Group (ASX:VNT), Probiotec (ASX:PBP), and Step One Clothing (ASX:STP). |
Morgans | PBP | 1 year ago |
Q A: Firebrick Pharma is just weeks away from finding out if it has cracked a cure for the common cold
Firebrick Pharma awaiting results of pivotal trial of its Nasodine nasal spray to treat the common cold Nasodine found to reduce the viral load of SARS-CoV-2, which causes Covid-19, in recent Phase 2 trial Nasodine could be game-changer fo... |
Stockhead | PBP | 1 year ago |
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money will go
Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month Steve Jobs used to say that the most... |
Stockhead | PBP | 1 year ago |
ASX Biotech Winners in July: Down but far from out, here’s why biotechs could stage a comeback
The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July The Covid-19 pandemic had produced windfalls for and attracted fa... |
Stockhead | PBP | 1 year ago |
Check Up: Brisbane based Vaxxas set to disrupt market with game-changing, needle-free vaccines
Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month The world is anticipating a “game changer” as Brisba... |
Stockhead | PBP | 1 year ago |
Check Up: Here’s the handful of ASX small cap health stocks that actually pay dividends
Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week When we talk about dividend-paying hea... |
Stockhead | PBP | 1 year ago |
ASX Biotech Winners in May: We’re finally seeing signs of life on the back of another clinical breakthrough
Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May There are clear signs the biotech sector is springing back to life after a disappointing 2... |
Stockhead | PBP | 1 year ago |
Check Up: Here’s how diabetes drugs can help you get off the beers and lose weight
Pfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of these weight loss drugs? Best and worst performing ASX biotechs over the past week Earlier this week, Pfizer surprised the market by say... |
Stockhead | PBP | 1 year ago |
Check Up Budget Edition: Which ASX healthcare stocks will reap benefits from the Budget?
The Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health and Telehealth also received significant funding allocations Here are the ASX stocks that could benefit Medicare, telehealth and mental... |
Stockhead | PBP | 1 year ago |
Pharma manufacturer Probiotec courts M&A interest, calls in Canterbury
Small-cap Probiotec Limited, which acts as a contract manufacturer for the likes of Pfizer and L’oreal, is understood to be fielding interest from suitors. |
AFR | PBP | 1 year ago |
Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m quarterly sales
Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s... |
Stockhead | PBP | 1 year ago |
US stocks rise after banks look to bail out First Republic
ShareCafeUS stocks rise after banks look to bail out First Republic Stocks rose Thursday as Wall Street grew increasingly optimistic after a group of banks said it would aid First Republic amid the industry’s crisis... |
ShareCafe | PBP | 1 year ago |
S&P 500 closes lower as investors digest Feb’s losses
ShareCafeS&P 500 closes lower as investors digest Feb’s losses The S&P 500 fell overnight, as traders struggled to recover their footing following a losing month and that bond yields have continued their cli... |
ShareCafe | PBP | 1 year ago |
FNArena Corporate Results Monitor – 28-02-2023
Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ABY)) - Adore Beauty ((AIM)) - Ai-Media Technologies ((AGI)) - Ainsworth Game Technology ((ART)) - Airtasker ((AKE)) - Allkem ((APM)) - APM Human Services International... |
FNArena | PBP | 1 year ago |
ASX Health Stocks: Most biotechs are still chasing maiden revenue, but here’s a few healthcare stocks with strong earnings
Alcidion increased sales significantly in the first half Cogstate sounds warning on outlook Probiotic had a super half Most biotech firms on the ASX are clinical stage companies, meaning they are still trying to prove that their drugs a... |
Stockhead | PBP | 1 year ago |
Check Up: The FDA refuses to give CBD a green light, but market doesn’t seem to care
The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry The US FDA announced last week that:... |
Stockhead | PBP | 1 year ago |
Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device
Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past... |
Stockhead | PBP | 1 year ago |
How out of favour Biotech has a PR problem and could learn from Dr Karl
ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and... |
Stockhead | PBP | 2 years ago |
Check Up: Only two healthcare IPOs from 2021 are gaining ground, could the rest be buying opportunities?
We take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks from 2021 have gained since listing We also look at the best and worst performing ASX stocks over the past month There were 191 ASX IPOs in... |
Stockhead | PBP | 2 years ago |
Check Up: Blood clots are a $55bn opportunity and these 2 ASX stocks are vying for a slice
Blood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks are in the blood clot space Top performing ASX healthcare stocks in the past month Blood clots were top of biotech news this week after re... |
Stockhead | PBP | 2 years ago |
2 ASX healthcare shares to buy that you’ve not heard of: expert
Healthcare is one of those industries that enjoys relatively stable demand through tougher economic times. With consecutive interest rises forcing Australians to close their wallets, this might be a consideration for the coming period. But... |
Motley Fool | PBP | 2 years ago |
US markets rise as EV battery integration grows rapidly under Biden Administration
ShareCafeUS markets rise as EV battery integration grows rapidly under Biden Administration US equities were mostly higher in fairly choppy Wednesday trading. The Nasdaq Composite ground higher in choppy trading on... |
ShareCafe | PBP | 2 years ago |
Metal prices under pressure as recession looms across the globe
ShareCafeMetal prices under pressure as recession looms across the globe US stocks slumped on Tuesday in a volatile trading session as investors weighed what strong economic data and rising rates mean for the Federa... |
ShareCafe | PBP | 2 years ago |
ASX Health Stocks: Giant Sonic and small cap Probiotic roll out the record results
Healthcare giants Sonic and EBOS report solid full year results Trajan offers handy forward guidance Probiotic delivers record revenues The news flow on healthcare today revolves around earnings results. Australia’s second biggest healthc... |
Stockhead | PBP | 2 years ago |